Clinical trials
Completed Sarcoma, Ewing trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 7 |
| 2010 | 6 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 19 |
| St. Jude Children's Research Hospital | 5 |
| Emory University | 4 |
| Children's Oncology Group | 3 |
| Eli Lilly and Company | 3 |
| Gradalis, Inc. | 3 |
| Grupo Espanol de Investigacion en Sarcomas | 3 |
| Istituto Ortopedico Rizzoli | 3 |
| Peking University People's Hospital | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma, Ewing | 102 |
| Rhabdomyosarcoma | 51 |
| Osteosarcoma | 47 |
| Sarcoma | 46 |
| Neuroblastoma | 37 |
| Wilms Tumor | 23 |
| Neoplasms | 15 |
| Neuroectodermal Tumors, Primitive, Peripheral | 13 |
| Rhabdoid Tumor | 13 |
| Medulloblastoma | 11 |
Trials
Showing 76 to 100 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.